470485-27-9

Upstream product

• 5292-21-7 Cyclohexylacetic acid 
• 108-46-3 recorcinol 
• 23860-35-7 cyclohexylacetic acid chloride 

Downstream Products

• 470485-26-8 2-cyclohexyl-7-hydroxy-4H-1-benzopyran-4-one 
• 1427550-06-8 1-[4-(benzyloxy)-2-hydroxyphenyl]-2-cyclohexylethanone 
• 1427550-19-3 13-cyclohexyl-3-{[2-(morpholin-4-yl)-5-(2-oxopyrrolidin-1-yl)benzyl]oxy}-6,7-dihydropyrazolo[5',1':2,3]imidazo[1,5-d][1,4]benzoxazepine-10-carboxylic acid 
• 1427550-16-0 methyl 13-cyclohexyl-3-{[2-(morpholin-4-yl)-5-(2-oxopyrrolidin-1-yl)benzyl]oxy}-6,7-dihydropyrazolo[5',1':2,3]imidazo[1,5-d][1,4]benzoxazepine-10-carboxylate 
• 1427550-12-6 13-cyclohexyl-3-hydroxy-6,7-dihydropyrazolo[5',1‘:2,3]imidazo[1,5-d][1,4]benzoxazepine-10-carboxylic acid 
• 1427550-11-5 3-(benzyloxy)-13-cyclohexyl-6,7-dihydropyrazolo[5',1':2,3]imidazo[1,5-d][1,4]benzoxazepine-10-carboxylic acid 
• 1427550-10-4 methyl 13-cyclohexyl-3-hydroxy-6,7-dihydropyrazolo[5',1':2,3]imidazo[1,5-d][1,4]benzoxazepine-10-carboxylate 
• 1427550-09-1 methyl 3-(benzyloxy)-13-cyclohexyl-6,7-dihydropyrazolo[5',1':2,3]imidazo[1,5-d][1,4]benzoxazepine-10-carboxylate 
• 1427550-08-0 1-[4-(benzyloxy)-2-(2-chloroethoxy)phenyl]-2-bromo-2-cyclohexylethanone 
• 1427550-07-9 1-[4-(benzyloxy)-2-(2-chloroethoxy)phenyl]-2-cyclohexylethanone 
• 500334-21-4 4-(2-cyclohexyl-ethyl)-resorcinol 

Relevant academic research and scientific papers

Development of 3-alkyl-6-methoxy-7-hydroxy-chromones (AMHCs) from natural isoflavones, a new class of fluorescent scaffolds for biological imaging

Starting from 7-hydroxyisoflavones, we developed a new class of fluorescent scaffolds, 3-alkyl-6-methoxy-7-hydroxy-chromones (AMHCs, MW ～ 205.19, λab ～ 350 nm, λem ～ 450 nm) via a trial and error process. AMHCs have the advantages of being a small molecular moiety, having strong fluorescence in basic buffers, reasonable solubility and stability, non-toxicity, and are conveniently linked to pharmacophores. AMHCs were successfully used in fluorescence microscopy imaging of cells and tissues. This journal is

COMPOUNDS FOR THE TREATMENT OF HCV

The present invention relates to viral polymerase inhibitors of formula (I), salts, solvates, hydrates, racemates, enatiomers and isomers thereof, in particular inhibitors of viral polymerases within the Flaviviridae family such as hepatitis C virus (HCV), processes for their preparation and their use in the treatment of Flaviviridae viral infection such as Hepatitis C virus (HCV) infections

2-Substituted 4-(thio)chromenone 6-O-sulfamates: Potent inhibitors of human steroid sulfatase

Steroid sulfatase (STS) has emerged as a highly attractive target for the therapy of a number of disorders. Starting with the known inhibitor estrone sulfamate (1) as lead compound and with the finding that steroid sulfamates containing a nonaromatic A-ri